Home>Topics>Stocks>Endo Pharmaceutical Holdings

Endo Pharmaceutical Holdings ENDP

  1. All
  2. Commentary
  3. Headlines
    1. The Market: Exaggerated Woes

      Headlines

      Tue, 14 Oct 2014

      Endo Pharmaceuticals ENDP announced July 11 that it no longer expects to file a new drug application for its ketoprofen pain-relief patch by the first

    2. Auxilium agrees to sale to Endo for $2.6B

      Headlines

      Thu, 9 Oct 2014

      closing price on Sept. 16, the day Endo International (NASDAQ: ENDP ) made public its purchase proposal. Endo's earlier rejected ..... owners may elect to receive consideration of all stock (0.488 ENDP shares for each share of AUXL), or all cash, or an equal mix

    3. QLT Left At The Altar

      Headlines

      Wed, 1 Oct 2014

      By Chris DeMuth Jr. : I don't recommend getting married. That is not to say that I regret being married and it is no commentary on my spouse. I simply don't recommend it. As with any commitment, close calls should be decided in favor of inactivity and caution. If someone is truly in love with a ...

    4. Endo settles vaginal mesh claims

      Headlines

      Wed, 1 Oct 2014

      Endo International (NASDAQ: ENDP ) reaches master settlement agreements with several of the remaining plaintiffs' lawyers relating to the product liability litigation

    5. Recro Pharma: An Overlooked Opportunity With Disproportionate Risk/Reward

      Headlines

      Tue, 30 Sep 2014

      with a "real" CEO. REPH is a specialty pharma company run by Gerri Henwood, one of the co-founders of AUXL. (The company ENDP is trying to buy for $2.2bn) The stock is trading below cash, therefore we are obviously not talking about the next AUXL

    6. Auxilium says Endo offer a bit light but is willing to talk

      Headlines

      Mon, 22 Sep 2014

      Pharmaceuticals' ( AUXL -0.3% ) BOD says that Endo International's ( ENDP -1.7% ) $2.2B bid "significantly undervalues" the company ..... that it maintains the right to engage in discussions with Endo. ENDP says that it is willing to work with AUXL on a deal. A marriage

    7. It Takes Less Than 15 Minutes To Buy VVUS Shares!

      Headlines

      Fri, 19 Sep 2014

      partner, Auxilium Pharmacueticals Inc. (NASDAQ: AUXL ), just recieved a takeover bid from Endo International (NASDAQ: ENDP ). Vivus Pharmaceuticals (NASDAQ: VVUS ) shares have fallen dramatically since approval of Qsymia , the second of three new

    8. Update: Auxilium Could Be Acquired By Endo, What Shareholders Should Do Now

      Headlines

      Thu, 18 Sep 2014

      By Andy Batts : Endo International (NASDAQ: ENDP ), a specialty healthcare company, offered a proposal to takeover Auxilium Pharmaceuticals (NASDAQ: AUXL ) for $2.2 billion

    9. Endo's Bid For Auxilium Makes Sense

      Headlines

      Thu, 18 Sep 2014

      By Stephen Simpson, CFA : Endo International (NASDAQ: ENDP ) has been very acquisitive over the past couple of years, using deals to not only leverage its tax-advantaged Irish domicile

    10. Wall Street Breakfast: Sony Warns Of $2.2B Net Loss

      Headlines

      Wed, 17 Sep 2014

      By Wall Street Breakfast : Economy Hours after Kiev granted "special status" to eastern regions of the country and granted them limited self rule, Ukraine and the EU ratified their long awaited association and free trade agreement, which sparked the Ukrainian revolution last February. Following the

    « Prev12345Next »
    Content Partners